Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.
Phillip H LamPoonam BhyanCherinne ArundelDaniel J DooleyHelen M SheriffSelma F MohammedGregory Y H LipCharity J MorganWilbert S AronowRichard M AllmanFinn WaagsteinAli AhmedPublished in: Clinical cardiology (2018)
In hospitalized patients with HFrEF receiving β-blockers, digoxin use was associated with a lower risk of 30-day all-cause readmission but not mortality, which persisted during longer follow-up.